CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: a refined target for radiotherapy trials?
Citation
Lee, C., Guinn, B.A., Brooks, S.E., Orchard, K. (2010) 'CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: a refined target for radiotherapy trials?' 149 (5):795-6Publisher
WileyJournal
British journal of haematologyPubMed ID
20230402Type
ArticleLanguage
enISSN
1365-2141Sponsors
Leukaemia and Lymphoma Research, Cancer Research U.K.ae974a485f413a2113503eed53cd6c53
10.1111/j.1365-2141.2010.08100.x